Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: A pilot study

Retina

Volumn 27, Issue 8, 2007, Pages 1074-1078

  Hirata, Akira ^a   Takano, Akiomi ^b   Inomata, Yasuya ^b   Yonemura, Naoko ^b   Sagara, Nina ^b   Tanihara, Hidenobu ^b  

^a SAGA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Plasmin; Proliferative diabetic retinopathy; Vitrectomy

Indexed keywords

PLASMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INCIDENCE; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINA TEAR; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURGICAL TECHNIQUE; VISUAL ACUITY; VITRECTOMY;

ADULT; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLASMIN; PROGNOSIS; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITRECTOMY;

EID: 37349126621     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3180592beb     Document Type: Article

References (8)

1. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology 2000;107:1607-1611.
2. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001;108:1902-1906.
3. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology 1998;105:1617-1620.
4. Asami T, Terasaki H, Kachi S, et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology 2004;111:231-237.
5. Azzolini C, D'Angelo A, Maestranzi G, et al. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol 2004;138:560-566.
6. Takano A, Hirata A, Inomata Y, et al. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol 2005;140:654-660.
7. Uemura A, Nakamura M, Kachi S, et al. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol 2005;123:209-213.
8. Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci 2005;46:3295-3299.